Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Radiation and Nuclear Countermeasures Program

This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.

View Slides

What's New

The Radiation and Nuclear Countermeasures Program, DAIT, NIAID is participating in the following Program Announcements:  PAR-16-093, Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01); PAR-16-094, Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21).  Standard NIH Receipt dates for R01 and R21s apply.

BAA-NIAID-DAIT-NIHAI2015042: Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Devices. Response date – March 22, 2016

RFA-HL-16-003: Collaborative Projects to Accelerate Research in Organ Fibrosis (R01) (co-funded by NIAID)—Receipt date Oct. 21, 2016

Pegfilgrastim Approved for Treatment of Acute Radiation Syndrome—Dec. 3, 2015

All Radiological and Nuclear Threats News Releases

News From NIAID-Supported Institutions

Last Updated February 12, 2016